ArticleThe Iowa orthopaedic journal2025
Patient Reported Outcomes for Maisonneuve Fractures using PROMIS Physical Function Scores.
Article in The Iowa orthopaedic journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Limited research exits surrounding Maisonneuve fractures due to rarity. Additionally, even less data has been published evaluating the patient reported outcomes of surgically treated Maisonneuve fractures using the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) and Pain Intensity (PI) score. The aim of this study was to put forth a cohort of patient reported outcomes using PROMIS PF and PROMIS PI. Methods: Maisonneuve fracture patients with minimum 12-month follow-up treated at a level-1 trauma center from 2006 to 2020 completed PROMIS PF and PROMIS PI tests. Medical records were reviewed to gather patient characteristics, mechanism of energy, operative variables, and complications. Results: The final cohort consisted of 28 patients with a mean follow up of 59.6 months with a mean time between injury and primary operation of 7.9 days. The mean PROMIS PF and PROMIS PI scores of the cohort were 56.3 (SD 10.8 [95% CI 15.9, 171.0] and 40.9 (SD 7.5 [95% CI 36,44]) respectively. The mean Foot and Ankle Ability Measure (FAAM) Activities of Daily Living (ADL) and FAAM Sports were 90.4 (15.4 [95% CI 84, 109] and 75.2 (SD 28.9 [95% CI 62, 91] respectively. Thirteen patients received syndesmotic screws only, nine received plate + syndesmotic screw, three received suture-button devices only, and three patients received syndesmotic screws + suture-button device. When the methods of syndesmotic fixation were divided into three groups, (1- syndesmotic screws only, 2-plate + syndesmotic screw, 3- suture-button device only and syndesmotic screw + suture-button device), the PROMIS PF scores for each treatment group was 60.2 (SD 8.5 [95% CI 54, 66]], 46.5 (SD 9.7 [95% CI 41, 53]), 62.8 (SD 9.7 [95% CI 54, 77]), respectively. The treatment group of plate + syndesmotic screw has significantly worse PROMIS PF compared to the syndesmotic screw only group. Conclusion: This study is the largest cohort utilizing PROMIS PF and PI to evaluate surgically treated Maisonneuve fractures. The resultant PROMIS PF an PI scores further demonstrate the favorable outcomes for surgical treatment of Maisonneuve fractures.
Indexed as
Identifiers
40606696PMC12212329What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.